Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension

  Free Subscription


Articles published in Chest

Retrieve available abstracts of 128 articles:
HTML format



Single Articles


    August 2021
  1. INAMPUDI C, Silverman D, Simon MA, Leary PJ, et al
    Pulmonary Hypertension in the Context of Heart Failure with Preserved Ejection Fraction.
    Chest. 2021 Aug 12. pii: S0012-3692(21)03666-7. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  2. BAUGHMAN RP, Shlobin OA, Gupta R, Engel PJ, et al
    Riociguat for Sarcoidosis Associated Pulmonary Hypertension: Results of a One Year Double Blind, Placebo Controlled Trial.
    Chest. 2021 Aug 4. pii: S0012-3692(21)03613-8. doi: 10.1016/j.chest.2021.07.2162
    PubMed     Abstract available


  3. TATAH J, Keen JL, Prisco SZ, Pritzker M, et al
    Iron Deficiency is Associated with More Severe Pulmonary Vascular Disease in Pulmonary Hypertension due to Chronic Lung Disease.
    Chest. 2021 Aug 2. pii: S0012-3692(21)03610-2. doi: 10.1016/j.chest.2021.07.2159
    PubMed    


  4. KLINGER JR
    Treatment of Pulmonary Hypertension Associated With COPD: Time for Another Look?
    Chest. 2021;160:409-410.
    PubMed    


    July 2021
  5. MONTANE BE, Fiore AM, Reznicek EC, Jain V, et al
    Optimal Tricuspid Regurgitation Velocity to Screen for Pulmonary Hypertension in Tertiary Referral Centers.
    Chest. 2021 Jul 1. pii: S0012-3692(21)01276-9. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


    June 2021
  6. KILICKIRAN AVCI B, Ozden Tok O, Kalangos A, Alkan Bozkaya T, et al
    A 19-Year-Old Pregnant Woman With Pulmonary Hypertension With Progressive Dyspnea.
    Chest. 2021;159:e371-e375.
    PubMed     Abstract available


    April 2021
  7. TRAMMELL AW, Hart CM
    Identifying New Targets for Treatment of Pulmonary Hypertension.
    Chest. 2021;159:1326-1327.
    PubMed    


    February 2021
  8. VIZZA CD, Hoeper MM, Huscher D, Pittrow D, et al
    Pulmonary hypertension in patients with chronic obstructive lung disease: results from COMPERA.
    Chest. 2021 Feb 10. pii: S0012-3692(21)00272-5. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  9. BRACK T
    Into Thin Air: A Step Forward to Counsel Patients With Pulmonary Hypertension Travelling to High Altitude.
    Chest. 2021;159:484-485.
    PubMed    


  10. ULRICH S, Mathai SC
    Performance Under Pressure: The Relevance of Pulmonary Vascular Response to Exercise Challenge in Scleroderma.
    Chest. 2021;159:481-483.
    PubMed    


  11. SYNN AJ, Li W, Hunninghake GM, Washko GR, et al
    Vascular Pruning on CT and Interstitial Lung Abnormalities in the Framingham Heart Study.
    Chest. 2021;159:663-672.
    PubMed     Abstract available


    January 2021
  12. KOVACS G, Zeder K, Rosenstock P, Avian A, et al
    Clinical impact of the new definition of pre-capillary pulmonary hypertension.
    Chest. 2021 Jan 5. pii: S0012-3692(20)35526-4. doi: 10.1016/j.chest.2020.
    PubMed    


  13. ZIREK F, Akova BS, Ozcan G, Fitoz S, et al
    A 2-Year-Old Boy With Hypoxemia, Pulmonary Hypertension, and Digital Clubbing.
    Chest. 2021;159:e45-e48.
    PubMed     Abstract available


  14. FORD HJ, LeVarge B
    The Pursuit of Risk Assessment and Stratification Tools in Pulmonary Arterial Hypertension: Have We Seen the Lite?
    Chest. 2021;159:14-16.
    PubMed    


  15. BENZA RL, Kanwar MK, Raina A, Scott JV, et al
    Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension.
    Chest. 2021;159:337-346.
    PubMed     Abstract available


  16. DUBROCK HM, Cartin-Ceba R, Channick RN, Kawut SM, et al
    Sex Differences in Portopulmonary Hypertension.
    Chest. 2021;159:328-336.
    PubMed     Abstract available


  17. THAYER TE, Levinson RT, Huang S, Assad T, et al
    BMI Is Causally Associated With Pulmonary Artery Pressure But Not Hemodynamic Evidence of Pulmonary Vascular Remodeling.
    Chest. 2021;159:302-310.
    PubMed     Abstract available


    December 2020
  18. WACKER J, Aggoun Y, Terraz S, Golay E, et al
    A 13-Year-Old Male With Diagnosed Idiopathic Pulmonary Hypertension: Is it Really Idiopathic?
    Chest. 2020;158:e295-e298.
    PubMed     Abstract available


  19. GUPTA S, Batt J, Bourbeau J, Chapman KR, et al
    Triaging Access to Critical Care Resources in Patients With Chronic Respiratory Diseases in the Event of a Major COVID-19 Surge: Key Highlights From the Canadian Thoracic Society (CTS) Position Statement.
    Chest. 2020;158:2270-2274.
    PubMed    


  20. KOURI A, Gupta S, Yadollahi A, Ryan CM, et al
    Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic.
    Chest. 2020;158:2502-2510.
    PubMed     Abstract available


    October 2020
  21. LAHM T, Hess E, Baron AE, Maddox TM, et al
    Renin-Angiotensin-Aldosterone System Inhibitor Use and Mortality in Pulmonary Hypertension: Insights from the Veterans Affairs CART Database.
    Chest. 2020 Oct 5. pii: S0012-3692(20)34851-0. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


    September 2020
  22. CHEREL B, Humbert M, LeBlanc F, Zambello R, et al
    Large granular lymphocyte leukemia and pre-capillary pulmonary hypertension.
    Chest. 2020 Sep 10. pii: S0012-3692(20)34353-1. doi: 10.1016/j.chest.2020.
    PubMed    


  23. SIMON R S, Laura C M, Mona L, Charlotte B, et al
    Effect of normobaric hypoxia on exercise performance in pulmonary hypertension - randomized trial.
    Chest. 2020 Sep 9. pii: S0012-3692(20)34370-1. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


    August 2020
  24. BADLAM JB, Badesch DB, Austin ED, Benza RL, et al
    United States Pulmonary Hypertension Scientific Registry (USPHSR): Baseline Characteristics.
    Chest. 2020 Aug 25. pii: S0012-3692(20)34279-3. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


    June 2020
  25. HEIDEN GI, Sobral JB, Goncalves Freitas CS, Pereira de Albuquerque AL, et al
    Mechanisms of exercise limitation and prevalence of pulmonary hypertension in pulmonary Langerhans cell histiocytosis.
    Chest. 2020 Jun 29. pii: S0012-3692(20)31823-7. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


    May 2020
  26. KING CS, Shlobin OA
    The Trouble with Group 3 Pulmonary Hypertension in Interstitial Lung Disease: Dilemmas in Diagnosis and the Conundrum of Treatment.
    Chest. 2020 May 6. pii: S0012-3692(20)30872-2. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  27. MASLONKA M, Miles M
    Pulmonary Hypertension, Eggs, and Bananas.
    Chest. 2020;157:1393-1394.
    PubMed    


    April 2020
  28. MARON BA
    Rebuttal From Dr Maron.
    Chest. 2020;157:769-770.
    PubMed    


  29. FRANTZ RP
    Rebuttal From Dr Frantz.
    Chest. 2020;157:768-769.
    PubMed    


  30. WHITE RJ, Lachant DJ
    Selexipag Use in Clinical Practice: Mind the Gap.
    Chest. 2020;157:761-763.
    PubMed    


  31. TISSOT N, Montani D, Seronde MF, Degano B, et al
    Venoocclusive Disease With Both Hepatic and Pulmonary Involvement.
    Chest. 2020;157:e107-e109.
    PubMed     Abstract available


  32. FRANTZ RP
    COUNTERPOINT: Should the New Definition of PH Be the Clinical Practice Standard? No.
    Chest. 2020;157:766-768.
    PubMed    


  33. MARON BA
    POINT: Should the New Definition of PH Be the Clinical Practice Standard? Yes.
    Chest. 2020;157:764-766.
    PubMed    


  34. HACHULLA E, Launay D, Boucly A, Mouthon L, et al
    Survival Improved in Patients Aged
    Chest. 2020;157:945-954.
    PubMed     Abstract available


  35. MCLAUGHLIN VV, Channick R, De Marco T, Farber HW, et al
    Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway Agents.
    Chest. 2020;157:955-965.
    PubMed     Abstract available


    March 2020
  36. BALASUBRAMANIAN A, Kolb TM, Damico RL, Hassoun PM, et al
    Diffusing Capacity is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.
    Chest. 2020 Mar 14. pii: S0012-3692(20)30445-1. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  37. NEWMAN JH
    Pulmonary Hypertension by the Method of Paul Wood.
    Chest. 2020 Mar 5. pii: S0012-3692(20)30428-1. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  38. AGARWALA P, Salzman SH
    Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement.
    Chest. 2020;157:603-611.
    PubMed     Abstract available


    February 2020
  39. NATHAN SD, Flaherty KR, Glassberg MK, Raghu G, et al
    A Randomized, double-blind, placebo-controlled study to assess the safety and efficacy of pulsed, inhaled nitric oxide (iNO) at a dose of 30 mcg/kg-IBW/hr (iNO 30) in subjects at risk of Pulmonary Hypertension associated with Pulmonary Fibrosis (PH-PF
    Chest. 2020 Feb 21. pii: S0012-3692(20)30327-5. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  40. MCCARRON EP, Sreenivasan S, Monaghan M
    Cardiac Magnetic Resonance Imaging in Pulmonary Hypertension.
    Chest. 2020;157:470.
    PubMed    


  41. ALTSCHUL E, Remy-Jardin M, Sulica R, Raoof S, et al
    Response.
    Chest. 2020;157:471.
    PubMed    


  42. VONK NOORDEGRAAF A, Bogaard HJ
    Restoring the Right Ventricle.
    Chest. 2020;157:251-252.
    PubMed    


  43. GAYEN SK, Abdelrahman AA, Preston IR, Petit RD, et al
    Vitamin C Deficiency-Induced Pulmonary Arterial Hypertension.
    Chest. 2020;157:e21-e23.
    PubMed     Abstract available


  44. D'ALTO M, Badagliacca R, Argiento P, Romeo E, et al
    Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension.
    Chest. 2020;157:376-383.
    PubMed     Abstract available


    January 2020
  45. SIMPSON CE, Damico RL, Hassoun PM, Martin LJ, et al
    Noninvasive prognostic biomarkers for left heart failure as predictors of survival in pulmonary arterial hypertension.
    Chest. 2020 Jan 24. pii: S0012-3692(20)30129-X. doi: 10.1016/j.chest.2019.
    PubMed     Abstract available


  46. CLADELLAS M, Garcia-Ribas C, Ble M, Gomez M, et al
    Impact of preoperative right heart chambers measurement in the evaluation of pulmonary hypertension after aortic valve replacement.
    Chest. 2020 Jan 17. pii: S0012-3692(20)30020-9. doi: 10.1016/j.chest.2019.
    PubMed     Abstract available


  47. GAINE S
    How the Right Heart Is Measuring Up in Pulmonary Hypertension.
    Chest. 2020;157:1-2.
    PubMed    


  48. BAX S, Jacob J, Ahmed R, Bredy C, et al
    Right Ventricular to Left Ventricular Ratio at CT Pulmonary Angiogram Predicts Mortality in Interstitial Lung Disease.
    Chest. 2020;157:89-98.
    PubMed     Abstract available


    September 2019
  49. ANDERSON JJ, Lau EM, Lavender M, Benza R, et al
    Retrospective validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort.
    Chest. 2019 Sep 26. pii: S0012-3692(19)33934.
    PubMed     Abstract available


    August 2019
  50. CRAWFORD TC, Leary PJ, Fraser C 3rd, Suarez-Pierre A, et al
    Impact of the New Pulmonary Hypertension Definition on Heart Transplant Outcomes: Expanding the Hemodynamic Risk Profile.
    Chest. 2019 Aug 22. pii: S0012-3692(19)33459-2. doi: 10.1016/j.chest.2019.
    PubMed     Abstract available


  51. FERNANDES CJ, Steigner ML, Piazza G, Goldhaber SZ, et al
    Collaborative Cardiology and Pulmonary Management of Pulmonary Hypertension.
    Chest. 2019;156:200-202.
    PubMed    


    July 2019
  52. TUDER RM, Cool CD
    Pulmonary Arteries and Microcirculation in COPD With Pulmonary Hypertension: Bystander or Culprit?
    Chest. 2019;156:4-6.
    PubMed    


  53. ROBBINS IM
    Pulmonary Edema After Initiation of Parenteral Prostaglandin Therapy: More Common Than We Think but How Clinically Important Is It?
    Chest. 2019;156:7-8.
    PubMed    


  54. KLINGER JR, Elliott G, Levine DJ, Bossone E, et al
    Response.
    Chest. 2019;156:187-188.
    PubMed    


  55. DURRANI J, Toor A
    Request to "Update" the 2019 Update of Guidelines for Management of Pulmonary Arterial Hypertension.
    Chest. 2019;156:187.
    PubMed    


  56. KHAN MS, Memon MM, Amin E, Yamani N, et al
    Use of Balloon Atrial Septostomy in Patients With Advanced Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
    Chest. 2019;156:53-63.
    PubMed     Abstract available


  57. KHAN NA, Khan RA, Tonelli AR, Highland KB, et al
    Pulmonary Edema Following Initiation of Parenteral Prostacyclin Therapy for Pulmonary Arterial Hypertension: A Retrospective Study.
    Chest. 2019;156:45-52.
    PubMed     Abstract available


    June 2019
  58. JALIL BA, Smith JS, El-Kersh K
    A 34-Year-Old Woman With Hoarseness of Voice and an Abnormal Echocardiogram.
    Chest. 2019;155:e163-e166.
    PubMed     Abstract available


    May 2019
  59. SINGH I, Oliveira RKF, Naeije R, Rahaghi FN, et al
    Pulmonary Vascular Distensibility and Early Pulmonary Vascular Remodeling in Pulmonary Hypertension.
    Chest. 2019 May 20. pii: S0012-3692(19)31063-3. doi: 10.1016/j.chest.2019.
    PubMed     Abstract available


  60. GILLMEYER KR, Lee MM, Link AP, Klings ES, et al
    Response.
    Chest. 2019;155:1077-1078.
    PubMed    


  61. CALLAHAN SJ, Papani R
    Pulmonary Arterial Hypertension: Too Complex for Physicians, Too Complex for ICD Diagnosis Codes.
    Chest. 2019;155:1077.
    PubMed    


  62. CHEMLA D, Boulate D, Weatherald J, Lau EMT, et al
    Golden Ratio and the Proportionality Between Pulmonary Pressure Components in Pulmonary Arterial Hypertension.
    Chest. 2019;155:991-998.
    PubMed     Abstract available


    April 2019
  63. ALTSCHUL E, Remy-Jardin M, Machnicki S, Sulica R, et al
    Imaging of pulmonary hypertension: Pictorial essay.
    Chest. 2019 Apr 11. pii: S0012-3692(19)30826-8. doi: 10.1016/j.chest.2019.
    PubMed     Abstract available


  64. ELLIOTT CG
    Real-World Data for Pulmonary Arterial Hypertension.
    Chest. 2019;155:653-654.
    PubMed    


  65. GILLMEYER KR, Lee MM, Link AP, Klings ES, et al
    Accuracy of Algorithms to Identify Pulmonary Arterial Hypertension in Administrative Data: A Systematic Review.
    Chest. 2019;155:680-688.
    PubMed     Abstract available


    March 2019
  66. BUNEL V, Guyard A, Dauriat G, Danel C, et al
    Pulmonary Arterial Histological Lesions in COPD Patients with Severe Pulmonary Hypertension.
    Chest. 2019 Mar 11. pii: S0012-3692(19)30616-6. doi: 10.1016/j.chest.2019.
    PubMed     Abstract available


  67. KLINGER JR, Elliott CG, Levine DJ, Bossone E, et al
    Therapy for Pulmonary Arterial Hypertension in Adults: Update of the CHEST Guideline and Expert Panel Report.
    Chest. 2019;155:565-586.
    PubMed     Abstract available


    February 2019
  68. BRAGANZA M, Shaw J, Solverson K, Vis D, et al
    A prospective evaluation of the diagnostic accuracy of the physical examination for pulmonary hypertension.
    Chest. 2019 Feb 28. pii: S0012-3692(19)30204-1. doi: 10.1016/j.chest.2019.
    PubMed     Abstract available


  69. DODSON MW, Allen-Brady K, Brown LM, Elliott CG, et al
    Chronic Thromboembolic Pulmonary Hypertension Cases Cluster in Families.
    Chest. 2019;155:384-390.
    PubMed     Abstract available


  70. D'ANDREA A, Stanziola AA, Saggar R, Saggar R, et al
    Right Ventricular Functional Reserve in Early-Stage Idiopathic Pulmonary Fibrosis: An Exercise Two-Dimensional Speckle Tracking Doppler Echocardiography Study.
    Chest. 2019;155:297-306.
    PubMed     Abstract available


    January 2019
  71. LEJEALLE C, Paradis V, Bruno O, de Raucourt E, et al
    Evidence for an Association Between Intrahepatic Vascular Changes and the Development of Hepatopulmonary Syndrome.
    Chest. 2019;155:123-136.
    PubMed     Abstract available


    August 2018
  72. HEMNES AR, Opotowsky AR, Assad TR, Xu M, et al
    Features Associated with Discordance between Pulmonary Arterial Wedge Pressure and Left Ventricular End Diastolic Pressure in Clinical Practice: Implications for Pulmonary Hypertension Classification.
    Chest. 2018 Aug 24. pii: S0012-3692(18)32250.
    PubMed     Abstract available


    July 2018
  73. TEJWANI V, Patel DC, Zein J, Guzman JA, et al
    Survival After an ICU Hospitalization for Pulmonary Hypertension.
    Chest. 2018;154:229-231.
    PubMed    


    May 2018
  74. KOLSTAD KD, Li S, Steen V, Chung L, et al
    Long-term Outcomes in Systemic Sclerosis Associated Pulmonary Arterial Hypertension from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS).
    Chest. 2018 May 16. pii: S0012-3692(18)30736-0. doi: 10.1016/j.chest.2018.
    PubMed     Abstract available


  75. TANIGUCHI Y, Brenot P, Jais X, Garcia C, et al
    Poor Subpleural Perfusion Predicts Failure after Balloon Pulmonary Angioplasty for non-operable Chronic Thromboembolic Pulmonary Hypertension.
    Chest. 2018 May 3. pii: S0012-3692(18)30659-7. doi: 10.1016/j.chest.2018.
    PubMed     Abstract available


    April 2018
  76. MATHAI SC, Mathew S
    Breathing (and Coding?) a Bit Easier: Changes to International Classification of Disease Coding for Pulmonary Hypertension.
    Chest. 2018 Apr 20. pii: S0012-3692(18)30568-3. doi: 10.1016/j.chest.2018.
    PubMed     Abstract available


    January 2018
  77. NAEIJE R, Saggar R, Badesch D, Rajagopalan S, et al
    Exercise-Induced Pulmonary Hypertension Translating Pathophysiological Concepts into Clinical Practice.
    Chest. 2018 Jan 27. pii: S0012-3692(18)30161-2. doi: 10.1016/j.chest.2018.
    PubMed     Abstract available


    December 2017
  78. KHOURI C, Lepelley M, Roustit M, Montastruc F, et al
    Comparative safety of drugs targeting the nitric oxide pathway in pulmonary hypertension: a mixed approach combining a meta-analysis of clinical trials and a disproportionality analysis from the WHO pharmacovigilance database.
    Chest. 2017 Dec 21. pii: S0012-3692(17)33265-8. doi: 10.1016/j.chest.2017.
    PubMed     Abstract available


  79. HILL NS, Gillespie MN, McMurtry IF
    Fifty Years of Monocrotaline-Induced Pulmonary Hypertension: What Has It Meant to the Field?
    Chest. 2017;152:1106-1108.
    PubMed    


    October 2017
  80. CHADDHA U, Puscas I, Prosper A, Ganesh S, et al
    A 63-Year-Old Woman With Neurofibromatosis Type 1 and Pulmonary Hypertension With Worsening Hypoxemia.
    Chest. 2017;152:e89-e93.
    PubMed     Abstract available


    August 2017
  81. HACHULLA E, Jais X, Cinquetti G, Clerson P, et al
    Pulmonary arterial hypertension associated with systemic lupus: results from the French Pulmonary Hypertension Registry.
    Chest. 2017 Aug 26. pii: S0012-3692(17)31430-7. doi: 10.1016/j.chest.2017.
    PubMed     Abstract available


    July 2017
  82. RAMJUG S, Hussain N, Hurdman J, Billings C, et al
    Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
    Chest. 2017;152:92-102.
    PubMed     Abstract available


    June 2017
  83. KAY JM
    Crotalaria (Monocrotaline) Pulmonary Hypertension: The Fiftieth Anniversary.
    Chest. 2017 Jun 19. pii: S0012-3692(17)31082-6. doi: 10.1016/j.chest.2017.
    PubMed    


  84. HARARI S, Elia D, Humbert M
    Pulmonary hypertension in parenchymal lung diseases: any future for new therapies?
    Chest. 2017 Jun 16. pii: S0012-3692(17)31077-2. doi: 10.1016/j.chest.2017.
    PubMed     Abstract available


  85. WAXMAN AB, McElderry HT, Gomberg-Maitland M, Burke MC, et al
    Totally Implantable Intravenous Treprostinil Therapy in Pulmonary Hypertension: Assessment of the Implantation Procedure.
    Chest. 2017 Jun 2. pii: S0012-3692(17)31021-8. doi: 10.1016/j.chest.2017.
    PubMed     Abstract available


    May 2017
  86. JOSE A, King CS, Shlobin OA, Kiernan JM, et al
    Ventricular diastolic pressure ratio as a marker of treatment response in pulmonary hypertension.
    Chest. 2017 May 17. pii: S0012-3692(17)30929-7. doi: 10.1016/j.chest.2017.
    PubMed     Abstract available


  87. AVIRAM G, Rozenbaum Z, Ziv-Baran T, Berliner S, et al
    Identification of Pulmonary Hypertension Caused by Left Heart Disease (World Health Organization Group 2) Based on Cardiac Chamber Volumes Derived from Chest CT.
    Chest. 2017 May 12. pii: S0012-3692(17)30917-0. doi: 10.1016/j.chest.2017.
    PubMed     Abstract available


  88. RAEISI-GIGLOU P, Wang XF, Dakkak W, Bair N, et al
    Effect of Weight on Parenteral Prostacyclin Analogues Dosing in Pulmonary Hypertension.
    Chest. 2017;151:1189-1192.
    PubMed    


    April 2017
  89. BEST DH, Sumner KL, Smith BP, Damjanovich-Colmenares K, et al
    EIF2AK4 Mutations in Patients Diagnosed With Pulmonary Arterial Hypertension.
    Chest. 2017;151:821-828.
    PubMed     Abstract available


    March 2017
  90. TAKEI M, Kawakami T, Kataoka M, Kuwahira I, et al
    Elucidating the Ventilation/Perfusion Mismatch and Reduction of Diffusing Capacity for Carbon Monoxide in Chronic Thromboembolic Pulmonary Hypertension.
    Chest. 2017;151:725-726.
    PubMed    


  91. ZHOU Q, Wang D, Liu Y, Yang X, et al
    Solnatide Demonstrates Profound Therapeutic Activity in a Rat Model of Pulmonary Edema Induced by Acute Hypobaric Hypoxia and Exercise.
    Chest. 2017;151:658-667.
    PubMed     Abstract available


    January 2017
  92. MEHTA S, Sastry BK, Souza R, Torbicki A, et al
    Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial.
    Chest. 2017;151:106-118.
    PubMed     Abstract available


  93. JAIN S, Khera R, Girotra S, Badesch D, et al
    Comparative Effectiveness of Pharmacologic Interventions for Pulmonary Arterial Hypertension: A Systematic Review and Network Meta-Analysis.
    Chest. 2017;151:90-105.
    PubMed     Abstract available


    December 2016
  94. ZUCKER MJ
    Point: Should wireless pulmonary artery hemodynamic monitoring be used to monitor patients with pulmonary hypertension? YES.
    Chest. 2016 Dec 22. pii: S0012-3692(16)62632-6. doi: 10.1016/j.chest.2016.
    PubMed    


  95. HEMNES AR
    Counterpoint: Should wireless pulmonary artery hemodynamic monitoring be used to monitor patients with pulmonary hypertension? No.
    Chest. 2016 Dec 22. pii: S0012-3692(16)62629-6. doi: 10.1016/j.chest.2016.
    PubMed    


    November 2016
  96. SAHAY S, Melendres-Groves L, Pawar L, Cajigas HR, et al
    Pulmonary Hypertension Care Center Network Improving care and outcomes in PH.
    Chest. 2016 Nov 3. pii: S0012-3692(16)62331-0. doi: 10.1016/j.chest.2016.
    PubMed     Abstract available


    October 2016
  97. AKIZUKI M, Serizawa N, Ueno A, Adachi T, et al
    Effect of balloon pulmonary angioplasty on respiratory function in patients with chronic thromboembolic pulmonary hypertension.
    Chest. 2016 Oct 13. pii: S0012-3692(16)60761-4. doi: 10.1016/j.chest.2016.
    PubMed     Abstract available


    September 2016
  98. KATAOKA M, Momose Y, Aimi Y, Fukuda K, et al
    Familial Chronic Thromboembolic Pulmonary Hypertension in a Pair of Japanese Brothers.
    Chest. 2016;150:748-9.
    PubMed    


    August 2016
  99. D'ALTO M, Romeo E, Argiento P, Motoji Y, et al
    Clinical relevance of fluid challenge in patients evaluated for pulmonary hypertension.
    Chest. 2016 Aug 26. pii: S0012-3692(16)57833.
    PubMed     Abstract available


  100. SHLOBIN OA, Brown AW, Nathan SD
    Pulmonary Hypertension in Diffuse Parenchymal Lung Diseases.
    Chest. 2016 Aug 20. pii: S0012-3692(16)56163-7. doi: 10.1016/j.chest.2016.
    PubMed     Abstract available


    July 2016
  101. BOURGE RC, Waxman AB, Gomberg-Maitland M, Shapiro SM, et al
    Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial.
    Chest. 2016;150:27-34.
    PubMed     Abstract available


  102. MATURA LA, Shou H, Fritz JS, Smith KA, et al
    Physical Activity and Symptoms in Pulmonary Arterial Hypertension.
    Chest. 2016;150:46-56.
    PubMed     Abstract available


    June 2016
  103. GHOFRANI HA, Humbert M, Langleben D, Schermuly R, et al
    Riociguat: Mode of action and clinical development in pulmonary hypertension.
    Chest. 2016 Jun 2. pii: S0012-3692(16)49111-7. doi: 10.1016/j.chest.2016.
    PubMed     Abstract available


  104. HUERTAS A, Phan C, Bordenave J, Tu L, et al
    Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension.
    Chest. 2016;149:1482-93.
    PubMed     Abstract available


    May 2016
  105. FRITZ JS, Smith KA
    The Pulmonary Hypertension Consult: Clinical and Coding Considerations.
    Chest. 2016 May 14. pii: S0012-3692(16)49006-9. doi: 10.1016/j.chest.2016.
    PubMed     Abstract available


  106. ROSE JA, Cleveland JM, Rao Y, Minai OA, et al
    Effect of Age on Phenotype and Outcomes in Pulmonary Arterial Hypertension Trials.
    Chest. 2016;149:1234-44.
    PubMed     Abstract available


  107. MAR PL, Nwazue V, Black BK, Biaggioni I, et al
    Valsalva Maneuver in Pulmonary Arterial Hypertension: Susceptibility to Syncope and Autonomic Dysfunction.
    Chest. 2016;149:1252-60.
    PubMed     Abstract available


  108. MEHARI A, Klings ES
    Chronic Pulmonary Complications of Sickle Cell Disease.
    Chest. 2016;149:1313-24.
    PubMed     Abstract available


  109. WELLS JM, Morrison JB, Bhatt SP, Nath H, et al
    Pulmonary Artery Enlargement Is Associated With Cardiac Injury During Severe Exacerbations of COPD.
    Chest. 2016;149:1197-204.
    PubMed     Abstract available


    April 2016
  110. DESMARAIS J, Elliott CG
    Familial Chronic Thromboembolic Pulmonary Hypertension.
    Chest. 2016;149:e99-e101.
    PubMed     Abstract available


  111. KWON Y, Gomberg-Maitland M, Pritzker M, Thenappan T, et al
    Telangiectasia and Pulmonary Arterial Hypertension Following Treatment With Trastuzumab Emtansine: A Case Report.
    Chest. 2016;149:e103-5.
    PubMed     Abstract available


  112. REXHAJ E, Rimoldi SF, Pratali L, Brenner R, et al
    Sleep-Disordered Breathing and Vascular Function in Patients With Chronic Mountain Sickness and Healthy High-Altitude Dwellers.
    Chest. 2016;149:991-8.
    PubMed     Abstract available


    March 2016
  113. ELLIOTT CG
    Use of Parenteral Prostanoids: Important Insights for CHEST Physicians.
    Chest. 2016;149:615-6.
    PubMed    


  114. RENARD S, Borentain P, Salaun E, Benhaourech S, et al
    Severe Pulmonary Arterial Hypertension in Patients Treated for Hepatitis C With Sofosbuvir.
    Chest. 2016;149:e69-73.
    PubMed     Abstract available


  115. HAY BR, Pugh ME, Robbins IM, Hemnes AR, et al
    Parenteral Prostanoid Use at a Tertiary Referral Center: A Retrospective Cohort Study.
    Chest. 2016;149:660-6.
    PubMed     Abstract available


    February 2016
  116. HASLER ED, Muller-Mottet S, Furian M, Saxer S, et al
    Pressure-flow during exercise catheterization predicts survival in pulmonary hypertension.
    Chest. 2016 Feb 15. pii: S0012-3692(16)01253-8. doi: 10.1016/j.chest.2016.
    PubMed     Abstract available


  117. AGARWAL R, Gomberg-Maitland M
    Physiologic Markers of Exercise as a Potential Screening Tool for the Detection of Pulmonary Hypertension: "alpha" Few Steps Forward.
    Chest. 2016;149:295-7.
    PubMed    


  118. LAU EM, Chemla D, Godinas L, Zhu K, et al
    Loss of Vascular Distensibility During Exercise Is an Early Hemodynamic Marker of Pulmonary Vascular Disease.
    Chest. 2016;149:353-61.
    PubMed     Abstract available


    January 2016
  119. HOPPER RK, Abman SH, Ivy DD
    Persistent Challenges in Pediatric Pulmonary Hypertension.
    Chest. 2016 Jan 22. pii: S0012-3692(16)00469-4. doi: 10.1016/j.chest.2016.
    PubMed     Abstract available


    October 2015
  120. GERGES C, Gerges M, Skoro-Sajer N, Zhou Y, et al
    Hemodynamic thresholds for pre-capillary pulmonary hypertension.
    Chest. 2015 Oct 22. doi: 10.1378/chest.15-0928.
    PubMed     Abstract available


  121. RICHTER SE, Roberts KE, Preston IR, Hill NS, et al
    A simple derived prediction score for the identification of an elevated pulmonary artery wedge pressure using pre-catheterization clinical data in patients referred to a pulmonary hypertension center.
    Chest. 2015 Oct 22. doi: 10.1378/chest.15-0819.
    PubMed     Abstract available


  122. BONHAM CA, Oldham JM, Gomberg-Maitland M, Vij R, et al
    Prostacyclin and Oral Vasodilator Therapy in Sarcoidosis-Associated Pulmonary Hypertension: A Retrospective Case Series.
    Chest. 2015;148:1055-62.
    PubMed     Abstract available


  123. HAUTEFORT A, Girerd B, Montani D, Cohen-Kaminsky S, et al
    Response.
    Chest. 2015;148:e132-3.
    PubMed    


  124. HARBAUM L, Oqueka T, Glatzel A, Hennigs JK, et al
    Does circulating IL-17 identify a subset of patients with idiopathic pulmonary arterial hypertension?
    Chest. 2015;148:e131-2.
    PubMed    


  125. GAZZANA MB, Knorst MM
    Therapy for pulmonary arterial hypertension: approved dosages should be prescribed in clinical practice.
    Chest. 2015;148:e126.
    PubMed    


  126. FARBER HW, Miller DP, Poms AD, Badesch DB, et al
    Five-Year outcomes of patients enrolled in the REVEAL Registry.
    Chest. 2015;148:1043-54.
    PubMed     Abstract available


    September 2015
  127. PLOEGSTRA MJ, Arjaans S, Zijlstra WM, Douwes JM, et al
    Clinical Worsening as Composite Study End Point in Pediatric Pulmonary Arterial Hypertension.
    Chest. 2015;148:655-66.
    PubMed     Abstract available


    January 2015
  128. GUAZZI M, Naeije R, Arena R, Corra U, et al
    Echocardiography of Right Ventriculo-Arterial Coupling Combined to Cardiopulmonary Exercise Testing to Predict Outcome in Heart Failure.
    Chest. 2015 Jan 29. doi: 10.1378/chest.14-2065.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: